Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine

Journal Article · Sat Jun 01 00:00:00 EDT 1985 · J. Nucl. Med.; (United States)

OSTI ID:5416049

Sone, T; Fukunaga, M; Otsuka, N; Morita, R; Muranaka, A; Yanagimoto, S; Tomomitsu, T; Nakayama, H; Harada, T

A patient in whom metastatic medullary thyroid cancer was diagnosed underwent a scintigraphic examination using (/sup 131/I)MIBG. Multiple hot lesions and diffuse hepatic uptake were noted corresponding to bone and liver metastases. Iodine-131 MIBG may prove to be useful for scintigraphic localization and for the treatment of medullary thyroid cancer as in pheochromocytoma and neuroblastoma.

• Research Organization: Kawasaki Medical School, Okayama-ken, Japan
• OSTI ID: 5416049
• Journal Information: J. Nucl. Med.; (United States), Vol. 26:6
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
METASTASES
DIAGNOSIS
THYROID
SCINTISCANNING
GUANIDINES
IODINE 131
ISOMERIC NUCLEI
LIVER
ORGANIC IODINE COMPOUNDS
PATIENTS
TECHNETIUM 99
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARBONIC ACID DERIVATIVES
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DIGESTIVE SYSTEM
ENDOCRINE GLANDS
GLANDS
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
RADIOISOTOPE SCANNING
RADIOISOTOPES
TECHNETIUM ISOTOPES
YEARS LIVING RADIOISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics